why choose us

First received: November 26, 2024

Clinical Trial: A Phase I Study to Evaluate the Safety and Drug Allergy of HLB3-002 in Healthy Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase I Study to Evaluate the Safety and Drug Allergy of HLB3-002 in Healthy Volunteers

Brief Summary: Part I) multi-center, randomized, double-blind, placebo controlledPart II) multi-center, randomized, double-blind, placebo controlled

Read more